BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023

Rhea-AI Summary

BrainsWay Ltd. will report its third quarter 2023 financial results and operational highlights on November 15, 2023. The company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.

BURLINGTON, Mass. and JERUSALEM, Nov. 01, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter 2023 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, November 15, 2023. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

Date:	Wednesday, November 15, 2023
Time:	8:30 AM Eastern Time
United States:	877-407-3982
International:	201-493-6780
Conference ID:	13741239
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1634586&tp_key=97bf97c30c

The conference call will be broadcast live and will be available for replay for 30 days on the Company’s website, https://investors.brainsway.com/events-and-presentations/event-calendar. Please access the Company’s website at least 10 minutes ahead of the conference call to register.

About BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Burlington, MA and Jerusalem, Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.

Contacts: 
BrainsWay: 
Ido Marom 
Chief Financial Officer 
844-386-7001 ext. 5
Ido.Marom@BrainsWay.com 

Investors: 
Brian Ritchie
LifeSci Advisors
646-889-1200
britchie@lifesciadvisors.com

Media Contact:
Chris Boyer
844-386-7001 ext. 2
Chris.Boyer@BrainsWay.com

FAQ

When will BrainsWay report its third quarter 2023 financial results?

BrainsWay will report its third quarter 2023 financial results on November 15, 2023.

What is the conference call and webcast for?

The conference call and webcast are for discussing the financial results and providing an update on business operations.

What is the conference call dial-in and webcast information?

The conference call dial-in for the United States is 877-407-3982 and for international callers is 201-493-6780. The conference ID is 13741239. The webcast can be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1634586&tp_key=97bf97c30c.

Will the conference call be available for replay?

Yes, the conference call will be available for replay for 30 days on the Company's website.

Where can I access the conference call replay?

The conference call replay can be accessed on the Company's website at https://investors.brainsway.com/events-and-presentations/event-calendar.

When should I register for the conference call?

It is recommended to access the Company's website at least 10 minutes ahead of the conference call to register.